中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Drug similarity and structure-based screening of medicinal compounds to target macrodomain-I from SARS-CoV-2 to rescue the host immune system: a molecular dynamics study

文献类型:期刊论文

作者Babar, Zainib8; Zahra, Mubeen8; Khan, Mazhar7; Anwar, Munazza6; Noor, Kashif5; Suleman, Muhammad4; Ali, Shahid4; Ali, Syed Shujait4; Shah, Abdullah3; Hashmi, Huma Farooque2
刊名JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
关键词FREE-ENERGY CALCULATIONS ADP-RIBOSE REPLICATION BINDING CORONAVIRUSES SOFTWARE DOCKING AMBER
ISSN号0739-1102
DOI10.1080/07391102.2020.1815583
文献子类Article; Early Access
英文摘要The outbreak of the recent coronavirus (SARS-CoV-2), which causes a severe pneumonia infection, first identified in Wuhan, China, imposes significant risks to public health. Around the world, researchers are continuously trying to identify small molecule inhibitors or vaccine candidates by targeting different drug targets. The SARs-CoV-2 macrodomain-I, which helps in viral replication and hijacking the host immune system, is also a potential drug target. Hence, this study targeted viral macrodomain-I by using drug similarity, virtual screening, docking and re-docking approaches. A total of 64,043 compounds were screened, and potential hits were identified based on the docking score and interactions with the key residues. The top six hits were subjected to molecular dynamics simulation and Free energy calculations and repeated three times each. The per-residue energy decomposition analysis reported that these compounds significantly interact with Asp22, Ala38, Asn40, Val44, Phe144, Gly46, Gly47, Leu127, Ser128, Gly130, Ile131, Phe132 and Ala155 which are the critical active site residues. Here, we also used ADPr as a positive control to compare our results. Our results suggest that our identified hits by using such a complicated computational pipeline could inhibit the SARs-CoV-2 by targeting the macrodomain-1. We strongly recommend the experimental testing of these compounds, which could rescue the host immune system and could help to contain the disease caused by SARs-CoV-2. Communicated by Ramaswamy H. Sarma
学科主题Biochemistry & Molecular Biology ; Biophysics
WOS关键词Macrodomain-I ; immune system ; SARs-CoV-2 ; drug similarity ; free energy
语种英语
WOS记录号WOS:000567558000001
版本出版稿
源URL[http://202.127.25.143/handle/331003/3587]  
专题生化所2019-2020年发文
作者单位1.Riphah Int Univ, Fac Rehabil & Allied Hlth Sci, Islamabad, Pakistan,
2.Shandong Univ, Sch Life Sci, Jinan, Shandong, Peoples R China;
3.Shaheed Benazir Bhutto Univ, Dept Biotechnol, Sheringal, Dir, Pakistan;
4.Univ Swat, Ctr Biotechnol & Microbiol, Swat, Khyber Pakhtunk, Pakistan;
5.Univ Agr Faisalabad, Dept Plant Breeding & Genet, Punjab, Pakistan;
6.Quaid I Azam Univ, Fac Biol Sci, Dept Biochem, Islamabad, Pakistan;
7.Univ Sci & Technol China USTC, CAS Ctr Excellence Mol Cell Sci, Collaborat Innovat Ctr Genet & Dev,Hefei Natl Lab, Sch Life Sci,CAS Key Lab Innate Immun & Chron Dis, Hefei, Anhui, Peoples R China;
8.Univ Agr Faisalabad, Dept Bot, Faisalabad, Punjab, Pakistan;
推荐引用方式
GB/T 7714
Babar, Zainib,Zahra, Mubeen,Khan, Mazhar,et al. Drug similarity and structure-based screening of medicinal compounds to target macrodomain-I from SARS-CoV-2 to rescue the host immune system: a molecular dynamics study[J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS.
APA Babar, Zainib.,Zahra, Mubeen.,Khan, Mazhar.,Anwar, Munazza.,Noor, Kashif.,...&,.
MLA Babar, Zainib,et al."Drug similarity and structure-based screening of medicinal compounds to target macrodomain-I from SARS-CoV-2 to rescue the host immune system: a molecular dynamics study".JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

入库方式: OAI收割

来源:上海生物化学与细胞生物学研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。